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Department of Experimental Medicine, Laboratory for Experimental Medicine and Endocrinology,
Katholieke Universiteit Leuven, Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
Transgenic mouse models have contributed considerably to our understanding of the cellular and
molecular mechanisms by which androgens control spermatogenesis. Cell-selective ablation of
the androgen receptor (AR) in Sertoli cells (SC) results in a complete block in meiosis and unam-
biguously identifies the SC as the main cellular mediator of the effects of androgens on
spermatogenesis. This conclusion is corroborated by similar knockouts in other potential testicular
target cells. Mutations resulting in diminished expression of the AR or in alleles with increased
length of the CAG repeat mimick specific human forms of disturbed fertility that are not
accompanied by defects in male sexual development. Transcriptional profiling studies in mice
with cell-selective and general knockouts of the AR, searching for androgen-regulated genes relevant
to the control of spermatogenesis, have identified many candidate target genes. However, with the
exception of Rhox5, the identified subsets of genes show little overlap. Genes related to tubular
restructuring, cell junction dynamics, the cytoskeleton, solute transportation and vitamin A
metabolism are prominently present. Further research will be needed to decide which of these
genes are physiologically relevant and to identify genes that can be used as diagnostic tools or targets
to modulate the effects of androgens in spermatogenesis.
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The testis is not only the main source of androgens,
but it is also a key target for androgen action. Androgens
play a vital role in the control of spermatogenesis.
The mechanisms by which they exert this control,
however, remain poorly understood. The unravelling
of these mechanisms represents one of the major
challenges in andrology. Here, we will present an over-
view of our present understanding of the cellular and
molecular mechanisms by which androgens affect
germ cell development with special emphasis on the
contribution of a number of recently developed trans-
genic models in which androgen signalling in the testis
is disturbed.
Spermatogenesis is controlled by a hierarchical net-
work of regulatory systems. As nicely demonstrated by
recent germ cell xenotransplantation experiments,
germ cells themselves have a species-specific build-in
programme that guides them through a unique and
strictly timed sequence of steps of proliferation and
differentiation (de Franc¸a et al. 1998a; Brinster
2002). Successful completion of this programme,
however, depends on a succession of signals and cues
provided by the local environment (Skinner 1991;r for correspondence (guido.verhoeven@med.kuleuven.be).
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This local network of regulatory factors is ultimately
controlled by the endocrine system and in particular
by the gonadotropins follicle-stimulating hormone
(FSH) and luteinizing hormone (LH) that act as the
master switches that turn the entire system on or
off (Weinbauer & Nieschlag 1993; Sharpe 1994;
McLachlan et al. 2002).
Somatic cells play a key role in the control of germ
cell development. This is particularly true for the Ser-
toli cells (SC), epithelial cells that support developing
germs cells structurally and functionally throughout
their journey from the periphery to the centre of the
seminiferous tubules where they are ultimately
released as spermatozoa (Jegou 1993). At puberty
and concordant with the onset of spermatogenesis,
adjacent SC develop basally located specialized tight
junctions that divide the tubules into a basal compart-
ment containing mainly spermatogonia and an
adluminal compartment containing spermatocytes
and subsequent stages of germ cell development. In
this way, SC not only shield developing germ cells
from the immune system but also gain complete
control of the specific humoral and nutritional
environment, essential for germ cell development, in
the adluminal compartment (Setchell & Waites 1975;
Wong & Cheng 2005). SC communicate with adjacent
germ cells by specialized cell junctions (gap junctions,
ectoplasmic specializations (ES), tubulobulbarThis journal is q 2010 The Royal Society
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nutrients such as transferrin and pyruvate, and by
locally produced signalling molecules (Skinner 1991;
Verhoeven 1992; Jegou 1993; Mruk & Cheng 2004).
SC also affect Leydig cell development and function
(Verhoeven 1992; Boujrad et al. 1995). Peritubular
myoid cells play a key role in the production of the
basal lamina surrounding the tubules and maintain
bilateral interactions with SC and other testicular
cells (Skinner 1991; Dym 1994; Verhoeven et al.
2000). They also contribute to the contractility of
the tubules and the expulsion of spermatozoa.
Leydig cells, apart from their role in androgen pro-
duction, may provide other factors essential for germ
cell development and maintain bilateral interactions
with SC via cell signalling mechanisms that are only
partially understood (Sharpe et al. 1990; Verhoeven
1992).2. ANDROGENS AND THE CONTROL OF
GERM CELL DEVELOPMENT
The main hormones controlling germ cell develop-
ment are the gonadotropins FSH and LH. FSH acts
via specific G-protein-coupled receptors which are
widely accepted to be present exclusively on SC
(Plant & Marshall 2001). One of its main actions is
undoubtedly to promote SC proliferation in the imma-
ture testis (Orth 1984), but apart from this FSH exerts
a variety of effects at different stages of germ cell devel-
opment (Plant & Marshall 2001). LH acts on the
Leydig cells and is responsible for the physiological
levels of testosterone (T) in the male circulation and
for the high intratesticular T levels (up to 100 times
those observed in serum) that are apparently required
to maintain normal spermatogenesis.
In a physiological setting, both FSH and androgens
are required to initiate and maintain optimal sperm-
atogenesis (Weinbauer & Nieschlag 1993; Sharpe
1994; McLachlan et al. 2002). Under a number of
conditions, however, androgens are able to initiate,
maintain or restore spermatogenesis in the (virtual)
absence of FSH. Exogenous administration of physio-
logical amounts of androgens—as used in most
hormonal methods of male contraception—decreases
LH and accordingly causes a drop in intratesticular
T and a suppression of spermatogenesis. This effect
can be overcome by pharmacological amounts of
androgens, not only in rodents but also in higher
species such as the monkey (for review, see Sharpe
1994). A key role for androgens in the control of sperm-
atogenesis is further supported by a number of genetic
models. In a mouse model of hypogonadotropic
hypogonadism caused by a major deletion of
the GnRH gene (hpg mice), androgens (but not FSH)
are able to initiate qualitatively complete
spermatogenesis including the production of fertile
sperm (Singh et al. 1995; Handelsman et al. 1999;
Allan et al. 2001). Along the same lines, fertility is main-
tained, be it at a reduced level, in mice (Dierich et al.
1998; Abel et al. 2000) and men (Tapanainen et al.
1997) with inactivating mutations of the FSH-receptor
gene and in mice with a defect in the production of
the FSH-b-chain (Kumar et al. 1997). Surprisingly,Phil. Trans. R. Soc. B (2010)men with a deletion of the gene encoding FSH-b are
azoospermic and infertile (Maroulis et al. 1977; Lind-
stedt et al. 1998).
An impressive amount of work has been done to
define the specific contribution of FSH and androgens
to the control of germ cell development in various
species. As far as androgens are concerned, a variety
of data indicate that, in the rat, stages VII and VIII
of the spermatogenic cycle are particularly sensitive
to androgen action. Withdrawal of intratesticular
androgens by hypophysectomy (Russell & Clermont
1977), by chemical interference with gonadotropin
production or action (Russell et al. 1981), or by admin-
istration of the Leydig-cell-specific cytotoxin ethane
dimethanesulphonate (EDS) (Bartlett et al. 1986;
Cameron et al. 1993; Kerr et al. 1993) results in a
rapid increase in degenerating mid-pachytene sperm-
atocytes and step 7 and 19 spermatids characteristic
for stages VII and VIII. All these changes can be pre-
vented or reversed by administration of LH or T
(Russell & Clermont 1977; Kerr et al. 1993). Moreover,
endogenous T concentrations have been shown to
be higher at stage VIII than at any other stage of the
cycle (Parvinen 1982) and immunohistochemical
studies also reveal cyclic changes in the concentration
of the androgen receptor (AR) in SC culminating at
stage VII (Bremner et al. 1994; Vornberger et al.
1994). Parenthetically, a similar stage dependency
of AR expression has also been observed in the
human (Suarez-Quian et al. 1999). Finally, the most
marked effects of T on tubular protein synthesis and
secretion are also observed at stages VI–VIII (Sharpe
et al. 1992).
At least four steps in germ cell development display
clear-cut control by androgen action: spermatid
adhesion and development, spermiation, progression
through meiosis and spermatogonial differentiation.
For the former three steps, there is an obvious
relationship to stages VII and VIII of the cycle of
spermatogenesis.(a) Spermatid adhesion and development
A widely used experimental paradigm to study the
effects of androgens on spermatid adhesion and
development are rats treated with silastic implants
releasing low doses of Tand oestradiol (TE implants).
The main effect of these implants is that they suppress
LH secretion and reduce testicular T levels to approxi-
mately 3 per cent of the control with no or only minor
effects on FSH (McLachlan et al. 2002). As oestrogen
receptors have been described in testicular somatic
cells as well as in germ cells, the possibility of
additional direct effects of the oestradiol on testicular
cells may have to be considered (O’Donnell et al.
2001). One of the most striking effects observed after
treatment with TE implants is a complete block in
the conversion of round spermatids (RST) into
elongated spermatids (EST) (O’Donnell et al. 1994).
This block can be reversed by administration of high
doses of androgens. Detailed stereological analysis
reveals that conversion of RST between stages VII
and VIII is the principal point of T action. The dis-
appearance of RST and subsequent stages of germ
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large numbers of RST in the cauda epididymis, indi-
cating that premature detachment of RST is an
important underlying cause (O’Donnell et al. 1996).
Attempts to elucidate the mechanism(s) by which T
withdrawal results in premature sloughing of RST
have largely focused on the potential role of apical
ES, a testis-specific-actin-based type of adhesion junc-
tion that plays an important role in the adhesion of
RSTand EST to SC. In the rat, apical ES may already
be noted at the pachytene phase of meiosis in stage
VIII (de Franc¸a et al. 1993). A marked increase in
apical ES facing RST is noted in late stage VII and
early stage VIII and they persist up to step 19 sperm-
atids (O’Donnell et al. 2000). In the TE-treated rat,
at a time when step 8 RST are detaching from SC,
ES are apparently present and qualitatively normal,
indicating that premature sloughing is not due to the
absence of apical ES formation (O’Donnell et al.
2000). As a consequence the hypothesis has been
advanced that detachment of RST may be due to a
defect in the adhesion function of the relevant ES
junctions. At least three protein complexes have been
found to be associated with the apical ES and to be
involved in their dynamic interactions with germ
cells: the N-cadherin/b-catenin complex, the nectin/
afadin complex and the a6b1-integrin/laminin-g3
complex (Lee & Cheng 2004).
N-Cadherin has been suggested to be one of the
mediators of androgen-dependent adhesion of sperm-
atids. In the presence of FSH, T increases both the
expression of N-cadherin and the adhesion of isolated
spermatids to cultured immature rat SC (Cameron &
Muffly 1991; Perryman et al. 1996). This adhesion
is largely inhibited by an N-cadherin antiserum
(Perryman et al. 1996). Surprisingly, similar effects
of androgens were not observed when mature rather
than immature SC were co-cultured with spermatids
(Lampa et al. 1999). Moreover, in the mouse, oestra-
diol rather than T seems to be required for
N-cadherin induction in the presence of FSH
(MacCalman et al. 1997). Apart from the mentioned
changes in N-cadherin expression, androgen with-
drawal also results in a loss of N-cadherin/b-catenin
association accompanied by a surge in Tyr phos-
phorylation of b-catenin. The exact mechanisms
involved remain unknown, but a role has been
suggested for c-Src and myotubularin-related
protein 2. Interestingly, like N-cadherin, myotubu-
larin-related protein 2 and c-Src are induced by
androgens in SC-germ cell co-cultures and this induc-
tion is blocked by the antiandrogen cyproterone
acetate (Zhang et al. 2005).
In a similar fashion, T-withdrawal-induced sperm-
atid loss is accompanied by marked changes in the
dynamics of the a6b1-integrin/laminin-g3 complex.
Under physiological conditions, adhesion between
SC and spermatids is mediated at least in part by the
a6b1-integrin/laminin-g3 complex which, in turn,
interacts with the activated focal adhesion kinase
(pFAK)/c-Src complex in the SC to form cell-matrix
focal adhesion-like structures. TE-induced spermatid
loss causes dissociation of the pFAK/c-Src complex
from the a6b1-integrin, activation of the extracellularPhil. Trans. R. Soc. B (2010)signal-regulated kinase (ERK) signalling pathway and
destabilization of the adhesion function of the apical
ES (Wong et al. 2005).
(b) Spermiation
Spermatid release or spermiation occurs at stages VII–
VIII of the rat cycle and is very sensitive to T and/or
FSH withdrawal (Russell 1993; McLachlan et al.
2002). Also in monkeys and men treated with T-based
contraceptive regimens, spermiation failure followed by
spermatid retention with subsequent phagocytosis by
SC contributes considerably to the acute and chronic
suppression of sperm counts. Spermiation failure can
be induced both by selective withdrawal of androgens
and by selective suppression of FSH, but marked syner-
gistic effects between both hormones are evident (Saito
et al. 2000; Matthiesson et al. 2006). The mechanisms
bywhich hormonewithdrawal impairs spermatid release
remain poorly understood. Several aspects of the sper-
miation process, including the formation and
degradation of tubulobulbar complexes and the removal
of ES some 30 h before final spermatid disengagement,
are apparently not affected by hormone withdrawal.
Only the final disengagement between spermatids and
SC seems to be impaired (Beardsley & O’Donnell
2003). Several lines of investigation suggest a role for
a6b1-integrin and the associated phophorylated-FAK
in the disengagement process, but the precise mechan-
isms involved and their hormonal control remain a
matter of investigation (Beardsley et al. 2006).
(c) Progression through meiosis
In a variety of experimental models, it has been
demonstrated that suppression of endogenous andro-
gen production or action in the testis results in a
block early in meiosis and that concomitant adminis-
tration of T or one of its active 5a-reduced
metabolites permits completion of meiosis and
formation of spermatids (Steinberger 1971). Experi-
mental models used to support this contention
include hypophysectomized rats treated or not with
antisera directed against LH (Lostroh et al. 1963) or
with antiandrogens (de Franc¸a et al. 1998b) to further
reduce endogenous androgen production or action,
neonatal or adult rats receiving doses of oestrogens
capable of suppressing gonadotropin secretion
(Chowdhury & Steinberger 1975; Chemes et al.
1976) and immature rats treated with antisera directed
against LH (Chemes et al. 1979). Studies in T-treated
hpg mice (Handelsman et al. 1999) and recent trans-
genic models confirm the critical role of androgens
in the control of meiosis (see §5b,d).
(d) Spermatogonial proliferation and
differentiation
It is widely accepted that FSH plays a major role in the
control of spermatogonial proliferation (Sharpe 1994;
McLachlan et al. 2002). Under some conditions,
however, high intratesticular concentrations of T may
interfere with these early stages of germ cell develop-
ment. After irradiation, or administration of the toxic
nematocide dibromochloropropane for instance, sperm-
atogenesis in rats fails to recover owing to an inability of
1540 G. Verhoeven et al. Review. Androgens and spermatogenesis
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tiate (Shuttlesworth et al. 2000; Meistrich et al. 2003). A
similar defect is observed in a mouse strain that displays
a spermatogenic arrest after the first wave of spermato-
genesis (juvenile spermatogenic depletion or jsd mice;
Shetty et al. 2006). In all these models, suppression of
intratesticular T levels by administration of a GnRH
analogue or by other means results in gradual recovery
of spermatogonial differentiation, sometimes with com-
plete recovery of spermatogenesis. This effect is
enhanced by concordant administration of the antian-
drogen flutamide, indicating the involvement of an
AR-mediated process affecting testicular or extratesticu-
lar cells (Shetty et al. 2006). The nature of this
unexpected effect of T remains elusive but studies in
jsd mice suggest that T may indirectly affect testicular
temperature and that temperature-dependent factors
may be involved (Shetty et al. 2006). It is worth men-
tioning that high intratesticular T levels may also
impede the development of transplanted spermatogo-
nial stem cells. In fact, suppression of intratesticular T
by pretreatment of recipient mice with a GnRH agonist
markedly enhances colonization by donor cells (Ogawa
et al. 1998).3. MECHANISMS OF ANDROGEN ACTION AND
CONTROL OF SPERMATOGENESIS
The vast majority of the effects of androgens are
mediated by the AR, a modular protein of approxi-
mately 110 kDa, encoded by a single gene located on
the long arm of the X chromosome. The AR is a
member of the large family of ligand-activated nuclear
receptors. Inactivating mutations of the AR result in
partial or complete forms of androgen insensitivity
characterized by disturbances in the development of
the normal male phenotype and disturbances in fertil-
ity (Quigley et al. 1995). For a more detailed
discussion of the molecular mechanisms involved in
androgen action, we refer to recent overviews (Gao
et al. 2005; Heemers & Tindall 2007; Claessens et al.
2008). Here, we only present a schematic outline
with special attention to elements that may be relevant
to the mechanisms by which androgens control
spermatogenesis.
The classical genomic pathway is generally con-
sidered the main pathway by which androgens exert
their activities. In this pathway the AR is activated by
interaction with natural or synthetic androgens. The
activated receptor translocates to the nucleus, under-
goes increased phosphorylation and binds as a dimer
to recognition sequences known as androgen response
elements (ARE), located in the regulatory regions of
androgen responsive genes (Blok et al. 1996; Tyagi
et al. 2000; Gao et al. 2005; Heemers & Tindall
2007). The structure of these AREs displays consider-
able variability. ‘Classical AREs’ are inverted partial
repeats of 50-TGTTCT-30-like sequences separated
by three nucleotides. They do not distinguish between
the AR, the glucocorticoid receptor or the mineralo-
corticoid receptor. Apart from these classical AREs,
however, ‘selective AREs’ have been identified that
bind the AR more selectively. These selective AREs
are organized as direct rather than inverted repeats ofPhil. Trans. R. Soc. B (2010)the 50-TGTTCT-30-like sequences and they display
an alternative binding mode to the AR (Verrijdt et al.
2003). Binding of the AR to the DNA ultimately
results in the recruitment of a wide variety of
co-regulatory molecules or complexes which in turn
induce changes in the conformation of the chromatin
and/or facilitate interactions with the transcription
initiation machinery (McKenna et al. 1999; Heemers
& Tindall 2007). As a result, the expression of the tar-
geted genes is modulated and specific proteins are
induced or repressed. The mechanisms by which
different genes are affected in distinct target cells are
incompletely understood, but differences in chromatin
structure, nature and number of available AREs, avail-
ability of the AR and specific co-regulators certainly
play a role. It should be noted that not all the genomic
effects of androgens are the result of direct interactions
of the AR with AREs in the relevant gene. Many
effects of androgens are indirect or secondary to
androgen-induced changes in the production of tran-
scription factors, paracrine mediators or hormones
(Verhoeven & Swinnen 1999).
An important feature in the androgen signalling cas-
cade is the role played by active metabolites. In many
target tissues T, the main circulating androgen, is
converted into 5a-dihydrotestosterone (DHT), a
metabolite with a higher affinity for the AR and a
higher intrinsic activity (Wilson 1975). Two 5a-
reductases (type 1 and type 2) have been described
that are responsible for the conversion of T into
DHT (Russell & Wilson 1994). The vital role of
DHT for some of the effects of androgens is illustrated
by a typical form of pseudohermaphroditism (normal
internal virilization, defective external virilization)
observed in patients with congenital deficiency of the
5a-reductase type 2 (Wilson et al. 1993). Taking into
account that the intratesticular concentration of T by
far exceeds the concentration needed to saturate the
AR, conversion of T into DHT may be less crucial
in the testis except under conditions where the intra-
testicular concentration of T is decreased
(McLachlan et al. 2002). Similarly, other effects of T
depend on its conversion into 17b-oestradiol by the
cytochrome P450 aromatase and subsequent acti-
vation of the cognate oestrogen receptors ERa and
ERb (Wilson 1975; Nilsson & Gustafsson 2002).
Again, inability to catalyse this conversion or to acti-
vate the ER results in disturbances in some of the
expected androgen effects (O’Donnell et al. 2001).
The potential role of aromatization of T in the control
of spermatogenesis will be discussed elsewhere in this
issue.
Alternative signalling pathways have been suggested
by which androgens may affect the function of target
cells without a need for direct effects on gene
expression (Silva et al. 2002; Walker 2003). These
‘non-genomic’ pathways may account for some effects
of androgens that occur so rapidly that they cannot
depend on AR-DNA-mediated gene activation. They
could also provide a possible explanation for the intri-
guing observation that some effects of androgens in
the testis seem to require concentrations of androgens
that exceed the binding capacity of the classical AR.
The nature of these signalling pathways and their
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in this issue.
When we try to apply this general knowledge on
androgen signalling to the problem of androgens and
the control of spermatogenesis, there are obviously a
number of questions that need specific attention: (i)
the target cell(s) by with androgens act to control
germ cell development need to be identified; (ii) the
molecular pathways that link androgen-mediated sig-
nalling to the control of germ cell development need
to be unravelled; (iii) it remains to be explained why
normal spermatogenesis apparently requires concen-
trations of androgens that clearly exceed those
needed to saturate the classical AR; (iv) the role of
active metabolites such as DHT and 17b-oestradiol
in the control of spermatogenesis remains to be
defined. In this overview, we will mainly focus on the
first two questions.4. DEFECTS IN ANDROGEN SIGNALLING AND
DISTURBED FERTILITY IN MEN
Deficient androgen production, whether owing to a
primary defect at the level of the testis (Klinefelter syn-
drome, Leydig cell aplasia, genetic or drug-induced
defects in androgen biosynthesis and so on) or to a
dysfunction at the hypophyseo-hypothalamic level
(Kallmann’s syndrome, hypopituitarism, genetic or
drug-induced defects in LH secretion and so on), is
a well-known cause of male infertility. Disturbed
androgen action, however, may also result in male
infertility as clearly illustrated in patients with com-
plete and partial androgen insensitivity syndromes
(CAIS and PAIS). Moreover, there is growing evi-
dence that more limited defects in androgen action
may be responsible for some unexplained forms of
male infertility (for overview, see Hiort & Holterhus
2003; Ochsenkuhn & de Kretser 2003).
More than 500 mutations of the AR resulting in
CAIS or PAIS have been described to date. These
patients present with variable degrees of feminization,
maldescended testes and severely disrupted spermato-
genesis not proceeding beyond the gonocyte or
spermatogonial stages (Rutgers & Scully 1991). The
aberrant location of the testes precludes unambiguous
conclusions about the exact role of androgen insensi-
tivity in the spermatogenic defect. Nonetheless,
maturation of the seminiferous tubules and SC tends
to be more advanced in patients with PAIS than in
patients with CAIS (Muller 1984; Cassio et al.
1990). Moreover, even in patients with CAIS, there
are sometimes indications for residual effects of andro-
gens on the maturation of the seminiferous tubules. In
fact, certain CAIS patients show some development of
the epididymis or vasa deferentia, apparently reflecting
residual activity of the AR in the presence of high con-
centrations of androgens during development.
Interestingly, the same patients also display a higher
degree of seminiferous tubule maturation at puberty
than those without epididymides or vasa deferentia
(Hannema et al. 2006).
The most convincing argument for impaired andro-
gen action as a cause of idiopathic male infertility is the
identification of a number of mutations of the ARPhil. Trans. R. Soc. B (2010)resulting in patients that present with oligozoospermia
or azoospermia despite an otherwise normal male
phenotype (for overview, see Hiort & Holterhus
2003; Ochsenkuhn & de Kretser 2003). Some of
these mutations are accompanied by a diminished
capacity of the mutated AR to cause transactivation
of reporter constructs in vitro or by a combined
increase of Tand LH in vivo reflecting impaired andro-
gen responsiveness at the hypophyseo-hypothalamic
level. The fact that only spermatogenesis is affected
in these patients may indicate that this process requires
a higher level of androgen responsiveness or that
specific pathways of AR signalling are needed to sus-
tain germ cell development. For example, in one
patient, the mutated-AR allele impeded interaction
of the AR with a specific co-activator, TIF2, known
to play a role in androgen action in SC (Ghadessy
et al. 1999).
Not only mutations but also polymorphisms of the
AR may affect androgen responsiveness and fertility.
The most extensively studied polymorphism is
undoubtedly the length of the CAG repeat in exon 1,
encoding a polyglutamine stretch in the aminoterminal
domain of the AR. Extension of this repeat beyond its
normal range (9–36 repeats) results in an X-linked
recessive neurodegenerative disease (spinobulbar mus-
cular atrophy or Kennedy’s disease), characterized by
progressive flaccid proximal paralysis and muscle atro-
phy as well as endocrine disturbances including
gynaecomastia and progressive infertility (La Spada
et al. 1991). Long CAG alleles have been associated
with low intrinsic AR activity in reporter gene assays
but also with the accumulation of toxic aggregates in
androgen target cells. Interestingly, even within the
normal range of variation of the CAG repeats, shorter
repeat lengths seem to be associated with stronger
androgen action and larger repeat lengths with
weaker androgen action and disturbed spermato-
genesis. An inverse correlation between repeat length
and sperm concentration has been reported in
normal men (von Eckardstein et al. 2001) and a
large meta-analysis supports an association between
increased CAG repeat length and idiopathic male
infertility (Davis-Dao et al. 2007). However, these cor-
relations could not be confirmed by all authors and in
all populations studied, and the mechanisms involved
remain a matter of debate. Apart from the decreased
transactivation capacity of AR alleles with longer
CAG repeats, and the accumulation of toxic com-
plexes, increased CAG repeats seem to correlate with
increased serum T levels (perhaps reflecting an
attempt to compensate for the decreased androgen
responsiveness) and increased oestradiol levels, which
opens the possibility that some of the phenotypic con-
sequences may be related to increased oestrogen
receptor activation (Crabbe et al. 2007; Huhtaniemi
et al. 2009). More complex relationships between
CAG repeat lengths and male fertility have been
described. For example, in hormonal contraception
studies, longer repeats have been shown to increase
the chances of becoming azoospermic in males with
incomplete gonadotropin suppression (von Eckardstein
et al. 2002). Similarly, the CAG repeat length has been
shown to modify the susceptibility to adverse effects on
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pollutants (Bonde et al. 2008). The potential role of
a GGN repeat, also located in the first exon of the
AR, has been investigated less extensively, but short
GGN repeats have been linked to decreased semen
volume, possibly owing to suboptimal AR activity
(Erenpreiss et al. 2008).5. CONDITIONAL KNOCKOUTS OF THE AR:
IDENTIFICATION OF THE SC AS THE PRINCIPAL
MEDIATOR OF THE EFFECTS OF ANDROGENS
ON THE CONTROL OF SPERMATOGENESIS
As in the human, a general knockout of the AR in mice
results in a failure of the testes to descend in the scro-
tum, confounding studies on the role of androgen
signalling in the control of spermatogenesis. The
development of cell-selective knockout technology
has created possibilities to circumvent this problem
and has contributed considerably to our present
understanding of the role of somatic cells and germ
cells in the effects of androgens on spermatogenesis.
(a) Candidate androgen target cells in the testis
Theoretically, androgens might act either directly on
the germ cells or might affect germ cell development
indirectly by acting on somatic testicular cells such as
the SC and the peritubular myoid cells. A direct
action on germ cells via the classical AR seems rather
unlikely as the majority of evidence suggests that, at
least in rodents, post-natal germ cells do not express
the AR (Grootegoed et al. 1977; Bremner et al.
1994). Moreover, both chimeric mice carrying an
AR-deficient cell line (Lyon et al. 1975) and mice
receiving a testicular transplant of AR-defective sperm-
atogonial stem cells (Johnston et al. 2001) are
apparently able to produce fertile spermatozoa from
the AR-deficient germ cells. These experiments indi-
cate that the presence of a functional AR in somatic
cells is sufficient to allow normal germ cell develop-
ment. A possibility that cannot be ruled out is that
androgens might affect germ cell development by a
pathway not involving the AR.
If androgens act indirectly via somatic cells, SC are
prime candidates given their intimate morphological
and functional relationship with developing germ
cells (Jegou 1993; Sharpe 2006). Adult SC unequivo-
cally express the AR. Interestingly, however, AR
expression in SC starts quite late (post-natal days
3–5 in rat and mice and from 4 years of age with a pro-
gressive increase to 8 years in men) and this could be
the reason why they do not respond to the high intra-
testicular androgen concentration existing in foetal and
early post-natal life (Bremner et al. 1994; Chemes et al.
2008; Willems et al. 2009). Once spermatogenesis has
been initiated, cyclic changes in AR expression are
observed both in rodents and in men suggesting that
the germ cell complement affects AR concentration
and androgen responsiveness in SC (Bremner et al.
1994; Suarez-Quian et al. 1999).
A third candidate androgen target cell is the peritub-
ular myoid cell. These cells already express the AR
during foetal development (Chemes et al. 1976; Merlet
et al. 2007). Peritubular cells have relatively closePhil. Trans. R. Soc. B (2010)contacts with spermatogonia; moreover, they display
important bilateral interactions with SC that markedly
affect both basal- and androgen-induced SC functioning
(Skinner & Fritz 1985; Verhoeven & Cailleau 1988;
Skinner 1991). At least part of these interactions may
bemediated byoneormore androgen-inducedparacrine
agonist(s) produced by peritubular cells and con-
veniently referred to as P-Mod-S (Skinner et al. 1988;
Verhoeven et al. 2000). The nature of these agonist(s),
however, remains enigmatic.(b) Selective ablation of the AR in SC
The development of conditional knockout technology
has made it possible to explore more directly the role
of the AR in putative testicular target cells. One of
the first successful conditional knockouts in testicular
cells was the SC-selective knockout of the AR
(SCARKO) generated in our laboratory.
SCARKO mice were generated by Cre/loxP technol-
ogy. In this technology, a key role is played by the Cre
recombinase, an enzyme derived from the
bacteriophage P1 that mediates efficient site-specific
recombination between 34 bp recognition sequences
known as loxP sites. If the relevant loxP sites are
oriented in the same direction, recombination results
in removal of the intervening (‘floxed’) DNA. If the
loxP sites are oriented in opposite directions, recom-
bination causes reversible inversion (Nagy 2000). To
produce a cell-selective knockout of the AR, two
strains of transgenic mice need to be crossed. The
first strain should carry a mutated-AR allele in which
a critical region of the AR is floxed. Importantly, this
floxing should not disturb the production or activity
of the AR in mice carrying the allele. The second
mouse strain should express the Cre recombinase in
a cell-selective way. Crossing of the two strains results
in cell-selective removal of the critical region, and
accordingly in inactivation of the AR.
For the generation of SCARKO mice, we developed
a mouse strain in which exon 2 of the AR is floxed
(ARflox). This exon encodes the first zinc finger of
the DNA-binding domain of the AR which is crucial
for the recognition of AREs (Quigley et al. 1995;
Claessens et al. 2008). Moreover, removal of exon 2
disrupts the reading frame of the AR. The aminoterm-
inal part of the AR can still be produced but is
apparently instable and rapidly degraded (Hellwinkel
et al. 1999). The second mouse strain expressing the
Cre recombinase specifically in SC was developed by
Dr F. Guillou (Tours, France; Lecureuil et al. 2002).
This strain expresses the Cre recombinase under the
control of a promoter derived from the anti-Mu¨llerian
hormone gene (AMH). Male mice carrying this
AMH-Cre express the Cre recombinase selectively
and uniformly in all SC and expression starts as
early as day 15 post coitum. This implies that—in
the SCARKO model—the AR gene is inactivated in
SC more than a week before the onset of its expected
physiological expression. SCARKO mice were pro-
duced by crossing females heterozygous for the
mutant ARflox allele with males expressing AMH-Cre
(figure 1). As an additional control, mice with a gen-
eral AR knockout (ARKO) were also generated by
ARKO SCARKOcontrol
AMH
X
ubiquitous
Cre expression
SC-selective
Cre expression
ARflox/+
exon 2
X
ARKO SCARKO
all cells: all SC:
all other cells:
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e
sv
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Figure 1. Generation and phenotype of mice with a general (ARKO) or Sertoli cell-selective (SCARKO) knockout of the
androgen receptor. (a) Female mice, heterozygous for an AR allele with a floxed exon 2 (ARflox/þ; loxP sites are indicated
as red arrowheads) were crossed either with PGK-Cre mice, expressing the Cre recombinase ubiquitously, or with AMH-
Cre mice, expressing Cre selectively in SC, to generate ARKO or SCARKO mice, respectively. (b) SCARKO mice have nor-
mally descended testes (t) that are markedly reduced in size (28% of control). Ductus deferens (dd), seminal vesicles (sv)
and prostate (p) are normally developed. ARKO mice have very small testes that are located intraabdominally and male acces-
sory sex tissues are absent.
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the Cre recombinase ubiquitously under the control
of the phosphoglycerate kinase promoter (Lallemand
et al. 1998).
SCARKO mice display a unique and novel pheno-
type (De Gendt et al. 2004). In contrast with ARKO
males or mice with a spontaneous general AR inacti-
vation (Tfm), their external phenotype is male and
their growth curve follows that of male littermates
(table 1). Moreover, the typical male accessory sex
organs (prostate, epididymis, ductus deferens, seminal
vesicles) that are absent in ARKO and Tfm mice are
normally developed in the SCARKO. Importantly,
unlike ARKO and Tfm mice that display cryptorchid-
ism, SCARKO mice have normally descended testes.
However, despite their scrotal localization, these testes
are reduced to 28 per cent of the size observed in
normal adult littermates, suggesting severe impairment
of spermatogenesis.
Immunohistochemistry confirms the complete
absence of AR expression in the SC of SCARKO
mice and the preservation of this staining in peritubu-
lar myoid cells and interstitial cells. Functional
inactivation of the AR is confirmed by the loss of
expression of Rhox5, a prototypic gene known to be
directly regulated by the AR in SC. Interestingly, the
number of SC (as measured by stereological evaluation
of the nuclear volume) is unaffected in the SCARKOPhil. Trans. R. Soc. B (2010)but drastically reduced in the ARKO (Tan et al.
2005). Despite the fact that some biochemical par-
ameters (disappearing AMH expression and
increasing p27Kip1, GATA-1, sulphated glycoprotein-
2 expression) suggest normal maturation of SC,
there are also signs of incomplete maturation (defec-
tive migration of SC nuclei to the periphery of the
tubules; disturbed formation of SC tight barrier and
so on; see §7d). Similarly, transcript levels of function-
ally important genes in SCARKO SC are variably
affected (Tan et al. 2005; Denolet et al. 2006a). The
functional deficiency of the SCARKO SC is most
clearly illustrated by their inability to support normal
spermatogenesis. In fact, the drastic reduction in testi-
cular size is accompanied by a clear decrease in tubular
diameter and in tubular lumen formation, obser-
vations that suggest decreased testicular fluid
secretion, a process known to be controlled by andro-
gens (Jegou et al. 1983; Au et al. 1986; Sharpe et al.
1994). Stereological analysis shows that ablation of
the AR does not significantly affect the number of
spermatogonia but reduces the number of spermato-
cytes, RST and EST to 64 per cent, 3 per cent and 0
per cent of the control, respectively, pointing to a
block in meiosis (De Gendt et al. 2004). This block
is confirmed by a clear reduction in the expression of
several genes related to meiosis and the absence of
expression of post-meiotic markers such as transition
Table 1. Selected mouse models with defective androgen action. Quantitative values are expressed as a percentage of the
control. Values that differ significantly (p , 0.05) are indicated by an asterisk. ND, not determined.
ARKO SCARKO ARflox(ex1-neo)/Y AR113Q SPARKI
AR allele deletion of
exon 2
deletion of
exon 2
floxed exon 1 neo-
cassette in intron 1
CAG repeat
length 113
substitution of exon 3
by GR exon 4
expression of mutant
allele
ubiquitous SC ubiquitous ubiquitous ubiquitous
external phenotype female male male male male
development of male
reproductive tract
absent normal normal normal normal
testicular descent defective normal normal normal normal
testis weight 8%* 28%* 81%* 50% 67%*
seminal vesicle weight absent 108% 80% ND 55%*
body weight curve female male male ND male
serum LH 1435%* 178% 2429% 600% 113%
serum FSH 145%* 129%* 228% 23% 103%
spermatogenic defect rare
pachytenes
block in
meiosis
late spermiogenesis progressive
defect
hypospermatogenesis
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prisingly, although basal as well as human chorionic
gonadotropin (hCG)-stimulated levels of androgens
in SCARKO mice are undistinguishable from those
of normal controls (as also reflected by the normal
weight of male accessory sex tissues) and although
LH levels are not significantly increased, SCARKO
mice display a clear disturbance in Leydig cell develop-
ment (De Gendt et al. 2005). From day 20 onwards
the number of Leydig cells is reduced by approxi-
mately 40 per cent. The remaining Leydig cells
display an increase in size that probably contributes
to the ultimately normal levels of androgens. The
mechanism(s) by which AR ablation in SC affect(s)
Leydig cell development remain(s) elusive. Known
SC-derived growth factors such as platelet-derived
growth factor alpha (PDGF-A) (decreased production
in SCARKO) as well as unknown factors probably
contribute (Tan et al. 2005).
Two othermodels with an SC-selective ablation of the
AR have been described. The first one (the S-AR2/y
mouse) strongly resembles the SCARKO model
(Chang et al. 2004). Here too, exon 2 is targeted for
excision and SC-selective Cre expression is obtained
using the same AMH-Cre strain described above.
Only slight differences in phenotype are observed.
The S-AR2/y shows hypotestosteronaemia and a
4.5-fold increase in LH levels suggesting a more
pronounced impairment of Leydig cell function.
Nonetheless, seminal vesicle weight is not affected
(Wang et al. 2006). Minor technical differences or
diversity in genetic background might contribute to
this slight variation in phenotype. In the second
model, exon 1 is the targeted exon and loxP sites are
oriented in opposite directions (Holdcraft & Braun
2004). An important feature of this model is that a
hypomorphic phenotype is already observed in males
carrying the floxed receptor, most probably as a
result of the presence of a neomycin cassette, used in
the generation of these animals, that was not removed.
As a result, the floxed males (Arflox(ex1-neo)/Y) have
strongly reduced expression of the AR, a 19 per cent
reduction in testicular weight and disturbances in thePhil. Trans. R. Soc. B (2010)late stages of spermiogenesis near the time of spermia-
tion (table 1). Epididymal sperm numbers are only 3.9
per cent of normal. LH and T levels are increased 23-
fold and 40-fold, respectively. When females carrying
this AR allele are bred to males of an AMH-Cre
mouse strain (different from the one described
above), inversion of exon 1 is observed with selective
ablation of the AR in SC. Surprisingly, however, the
reduction in testis weight is less pronounced than in
the SCARKO or S-AR2/y (60% of the control versus
28% and 29%), the block in spermatogenesis is
observed at the level of the transition of RST into
EST, and the reduction in Rhox5 expression is less
pronounced than in the SCARKO. Taken together,
these data suggest that in this model the knockout of
the AR in SC is less complete, conceivably owing to
the fact that Cre-mediated inversion is in principle
reversible.(c) Selective ablation of the AR in germ cells,
peritubular myoid or Leydig cells
Conditional knockouts ablating the AR in testicular
cells other than SC have also been generated. A
germ-cell-selective knockout (G-AR2/y) was produced
using a mouse strain expressing Cre under the control
of the synaptonemal complex protein 1 (Sycp1) gene
promoter (Tsai et al. 2006). This promoter becomes
activated at the leptotene–zygotene stage of meiotic
development. No effects on spermatogenesis or fertil-
ity were observed. Complete AR ablation was seen in
15-week-old mice. Surprisingly, the efficiency of the
ablation decreased rapidly, thereafter reaching 0 per
cent at the age of 20 weeks. The mechanisms respon-
sible for this decrease in AR inactivation remain
elusive. Decreased Cre expression or methylation of
loxP sites might be involved.
Mice with an ablation of the AR in peritubular
myoid cells (PM-AR2/y) were generated using a
mouse strain expressing Cre under the control of the
transgelin (smooth muscle protein 22-a) promoter
(Tagln-Cre) (Zhang et al. 2006). PM-AR2/y mice dis-
played a 24 per cent reduction in testis size and
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likely, at least part of the observed defect was mediated
by impaired SC functioning as the expression of many
SC genes was affected. However, as Tagln-Cre mice
were originally used to express Cre in vascular
smooth muscle cells (Holtwick et al. 2002), a contri-
bution of the latter cells to the testicular phenotype
cannot completely be excluded.
Mice with an ablation of the AR in Leydig cells
(L-AR2/y) were generated using a strain of mice
expressing Cre under the control of the AMH type 2
receptor (Amhr2-Cre) (Xu et al. 2007). L-AR2/y
mice display a 67 per cent reduction in testicular
size, a block in spermatogenesis at the RST stage in
most testicular tubules and infertility. L-AR2/y mice
show disturbances in the expression of several steroid-
ogenic genes and a marked reduction in T secretion,
confirming the need for an active AR for normal
Leydig cell development. The decrease in androgen
production may largely account for the observed dis-
turbances in spermatogenesis. As Amhr2 may also be
expressed in SC (Jeyasuria et al. 2004), a contribution
of the latter cells to the spermatogenic arrest, however,
cannot completely be excluded.(d) A key role for the SC-AR
SC-selective knockout models such as the SCARKO
show, for the first time unambiguously, that the SC
is the main target cell by which androgens control
spermatogenesis. In fact, the spermatogenic defect
observed in these animals is as severe or even more
pronounced than that observed in models in which
androgen production in the testis is very drastically
reduced, such as rats receiving TE implants or mice
with an inactivating mutation of the LH receptor
(Zhang et al. 2001; McLachlan et al. 2002; Lei et al.
2004). The central role of the SC is corroborated by
studies on cell-selective knockout models targeting
the AR in the other candidate target cells: peritubular
myoid cells and germ cells. Furthermore, the
SCARKO model proves that the classical AR is the
main or only mediator by which androgens control
progression through meiosis. Whether the AR acts
exclusively through the genomic pathway or whether
AR-mediated signalling through non-genomic path-
ways is also involved merits further investigation.
Finally, the SCARKO model emphasizes that
completion of meiosis critically depends on androgens.
In this context, it is of interest to note that studies on
the induction of spermatogenesis by androgens in hpg
mice also suggest that meiosis represents the first
and most sensitive step in the control of germ cell
development by androgens (Singh et al. 1995;
Handelsman et al. 1999). Additional conclusions are
that the AR in SC is apparently not required for
normal testicular descent, that it is also not needed
to allow normal SC proliferation, but that normal
Leydig cell development and function depend on an
active AR in SC.
The SCARKO model does not exclude that some
specific effects of androgens may be mediated by
androgen action on cells different from SC. A nice
example is the effect of androgens on SC proliferation.Phil. Trans. R. Soc. B (2010)As already mentioned, animals with an ubiquitous KO
of the AR have a reduced number of SC while the SC
number is normal in the SCARKO, suggesting that
this effect may be mediated by androgen action in
other testicular cells such as the peritubular myoid
cells (Johnston et al. 2004; Tan et al. 2005). The
expression of a number of typical SC functional
marker genes (including transferrin, N-cadherin)
may also be modulated by androgen action in peritub-
ular cells and this may help to explain the slight
decrease in spermatogenesis observed in animals with
a peritubular KO of the AR. Parenthetically, the
above described inhibitory effects of androgens on
spermatogonial differentiation observed in models
such as the jsd mouse apparently also do not depend
on androgen action in SC. In fact, recent experiments
show that elimination of the AR in SC of jsd mice (by
the generation of SCARKO-jsd mice) does not restore
spermatogonial differentiation, whereas treatment of
the same mice with a GnRH antagonist and flutamide
stimulates recovery of spermatogenesis up to the sper-
matocyte stage (Wang et al. 2009). Replacement of
flutamide by T reverses the stimulatory effect on sper-
matogonial differentiation, confirming that androgens
are responsible for the observed arrest but also
indicating that this effect is not mediated by the AR
in SC.
An interesting extension of the SCARKOmodel has
been the generation of mice with a double knockout of
the FSH receptor (FSHRKO) and the AR in SC
(SCARKO). These mice (FSHRKO–SCARKO) pro-
vide a unique baseline control from which the direct
and specific actions and interactions of FSH and
androgens on SC function and the control of sperm-
atogenesis can be assessed (Abel et al. 2008).
Comparison of germ cell development in the
FSHRKO–SCARKO, the FSHRKO, the SCARKO
and the WT control confirms that FSH specifically
increases the number of SC and the number of sperm-
atogonia. The initial onset of meiosis is apparently
independent of direct hormonal regulation. In accord-
ance with earlier data (de Franc¸a et al. 1994), however,
both FSH and androgens have marked effects on the
maintenance of the meiotic germ cell population and
at this level their effects seem additive. Completion
of meiosis and entry in spermiogenesis are absolutely
dependent on androgens. Spermiogenesis can appar-
ently proceed without a requirement for FSH as
the ratio of RST to mature sperm in the FSHRKO is
similar to that in the control.6. OTHER MOUSE MODELS WITH MUTANT AR
ALLELES AFFECTING SC DEVELOPMENT AND
FUNCTION
A few other mouse models have been developed that
shed some light on the mechanisms mediating andro-
gen action in the testis and on male forms of infertility
related to disturbed androgen action (table 1).
As mentioned before, the Arflox(ex1-neo)/Y mouse rep-
resents a unique model of a partial defect in androgen
sensitivity (Holdcraft & Braun 2004). This mouse car-
ries an AR allele with a floxed exon 1 and a neomycin
selection cassette in intron 1. It was actually produced
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approach slightly different from the one used for the
SCARKO (see §5b). The presence of the neomycin
cassette in the floxed allele, however, results in a hypo-
morphic phenotype in mice carrying this allele and
causes a marked reduction in AR protein levels in
different target tissues including the testis. By external
examination, affected males are indistinguishable from
WT littermates and they also show male sexual behav-
iour. T as well as LH levels are markedly increased,
however, suggesting decreased AR function at the
hypophyseo-hypothalamic level. Moreover, testis
weight and epididymal sperm count are reduced by
19 per cent and 96 per cent of the control, respectively,
and microscopic evaluation reveals marked disturb-
ances in the later stages of spermatid differentiation
near the time of spermiation. This model apparently
strongly resembles the above mentioned minimal
forms of androgen insensitivity in men and confirms
that quantitatively normal spermatogenesis requires a
higher level of AR function than male sexual differen-
tiation. Moreover, it shows that a limited reduction in
androgen responsiveness may disturb more selectively
later stages of germ cell development.
A distinctive phenotype reflecting both partial and
selective androgen insensitivity is observed in the
SPARKI (SPecificity-affecting AR KnockIn) mouse
(Schauwaers et al. 2007). In this model, the second
zinc finger of the AR-DNA-binding domain has been
replaced by that of the glucocorticoid receptor, result-
ing in a chimaeric AR that still binds classical AREs
but is unable to recognize selective AREs. The
SPARKI mouse displays normal male development
and differentiation and normal levels of T and LH
(unlike the Arflox(ex1-neo)/Y), implying that selective
AREs are not essential for male development and
hypophyseo-hypothalamic feedback. Testis weight as
well as prostate and seminal vesicle weight, however,
are reduced to 67 per cent, 54 per cent and 55 per
cent, respectively, suggesting a role for selective
AREs in these target organs. The reduction in testis
weight can be accounted for by a reduction of the
number of SC (68% of control) but there also seems
to be a decrease in the number of RST and EST per
SC. SPARKI mice display normal mounting behaviour
and remain fertile but both number and size of their
litters are reduced by about 50 per cent. The involve-
ment of selective AREs in the testicular phenotype is
supported by the observation that on day 10, the tes-
ticular expression of Rhox5, a typical gene under the
control of a selective ARE, is markedly reduced
while the expression of two genes controlled by classi-
cal ARE (Eppin, PCI) is normal. The interesting
feature of this model is that it confirms, in an in vivo
system, that classical ARE and selective ARE drive
distinct biological processes and accordingly that it
may be possible to interfere with some of these pro-
cesses (reproductive function) without affecting
others (differentiation, behaviour, growth).
Two other transgenic mouse models have explored
the effects of long CAG repeats on testicular function.
In both models, very long repeat lengths were used.
In the first model, a full length human AR carrying
120 CAG repeats was overexpressed in all tissuesPhil. Trans. R. Soc. B (2010)(McManamny et al. 2002). A progressive decrease in
daily sperm production was noticed despite normal
levels of T and LH, suggesting normal androgen
action at the hypophyseo-hypothalamic level. The
defect was suggested to be due to a toxic gain of func-
tion of the mutated protein rather than to a decrease in
androgen responsiveness. In the second model, a 113
CAG repeat was inserted in the mouse AR (Yu et al.
2006). As in humans with Kennedy’s disease, a pro-
gressive disturbance of germ cell maturation resulting
in a decreased weight of the testis and infertility
(from the age of 10 weeks on) was observed
(table 1). Disturbances in the SC cytoskeleton were
noted coinciding or preceding the defect in germ cell
development. In contrast with the first model,
normal T but increased LH levels were observed,
suggesting diminished androgen responsiveness.
Rhox5 expression in the testis was normal, however,
indicating that here too the disturbances in spermato-
genesis are probably due to toxic effects related to the
expanded repeat rather than to diminished androgen
action.7. MOLECULAR MEDIATORS OF ANDROGEN
ACTION IN SC AFFECTING GERM CELL
DEVELOPMENT
The above summarized data clearly point to the SC as
the main target of androgen action; still, the molecular
mechanisms by which androgens ultimately affect
spermatogenesis via the SC remain poorly understood.
(a) Studies on isolated SC or SC lines
Studies searching for androgen-regulated genes in iso-
lated SC or SC lines have yielded rather disappointing
results. Disruption of the normal SC environment
apparently causes a loss of expression of characteristic
SC genes such as Rhox5 and a marked decrease in
androgen responsiveness (Denolet et al. 2006b). For
a number of genes, androgen-induced upregulation
(N-cadherin, cMyc, claudin 11, testin and so on) or
downregulation (plasminogen activator, TGF-b1)
can still be demonstrated, but the amplitude of the
observed effects is limited (for review, see Verhoeven
et al. 2008).
(b) Rhox5, a lead gene in the search for
molecular mediators of androgen action in SC
The most intriguing and strongly androgen-regulated
gene identified in SC remains a homeobox gene orig-
inally named Pem and presently known as Rhox5.
Rhox5 was discovered by a screening for developmen-
tally regulated genes and was subsequently found to
be expressed in several reproductive tissues including
testicular SC and principal cells of the caput epididymis
(Lindsey & Wilkinson 1996). In the mouse testis, a
massive androgen-dependent increase in expression is
observed between day 8 and adulthood. Orthologues
of Rhox5 that are also controlled by androgens in the
testis have been described in the rat and in the human
(Sutton et al. 1998; Wayne et al. 2002).
In mice, Rhox5 belongs to a large gene cluster of
reproductive homeobox genes on the X chromosome
(Rhox) devoted to regulate reproduction (MacLean
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promoter expressed in testis and epididymis and a
distal promoter transcribed in extra-embryonic tissues
and in ovarian granulosa cells (Shanker et al. 2008).
The proximal promoter harbours four AREs
(Hu et al. 2007) which selectively recognize the AR
(Barbulescu et al. 2001). Targeted disruption of
Rhox5 results in increased germ cell apoptosis, a
reduction in sperm count and motility and subfertility
(MacLean et al. 2005). Several Rhox5 target genes
have recently been identified by microarray analysis.
Marked effects have been observed on genes encoding
proteins involved in metabolism, including the tran-
scription factor PGC1a and the secreted proteins
INS2, adiponectin and resistin. Unc5c, a netrin recep-
tor known to trigger apoptosis in a ligand-dependent
fashion, was shown to be negatively regulated by
Rhox5. This finding is concordant with the fact that
Rhox5 ablation results in increased germ cell apoptosis
(Hu et al. 2007).(c) Microarray studies on intact testes
using ARKO models
As disruption of the normal cellular environment
impedes gene expression and androgen responsiveness
in isolated SC, identification of molecular targets of
androgen action may only be possible in the intact
testis. Three studies have used models with SC-
selective or general ablations of the AR to search for
such genes. Two additional studies have investigated
the effects of exogenous androgens on hypogonadal
or prepubertal mice testes.
A first AR-knockout study compared transcript
levels in testes derived from 10-day-old SCARKO
and control mice (Denolet et al. 2006a). Theoretically,
SCARKO mice represent an ideal experimental para-
digm to search for genes that depend on the AR in
SC for their expression. The age of 10 days was
selected as up to that time, at the onset of meiosis,
the composition of the testis in SCARKO and control
mice is indistinguishable and as effects of androgens
on Rhox5 expression were previously observed from
day 9 on. Microarray analysis revealed that a surpris-
ingly high number of genes (at least 692) were
already differentially expressed on day 10. Forty of
them (further referred to as ‘strongly regulated’)
displayed a difference of at least twofold (28 down-
regulated and 12 upregulated in the SCARKO). The
physiological relevance of the identified set of genes
was supported by the observation that Rhox5 displayed
the highest degree of differential expression, and that
the subset of strongly regulated genes included at
least three genes (Galgt1 (b-1,4-acetyl-
galactosaminyltransferase), PCI (protein C inhibitor)
and Eppin (a serine protease inhibitor)) that were
already known to cause male infertility when inacti-
vated, and at least six genes (Rhox5, Eppin, Gpd1
(glycerol-3-phosphate dehydrogenase 1), Tubb3
(tubulin-b3), Tpd52l1 (tumour protein D52-like 1)
and PCI ) for which there was previous evidence for
androgen regulation in the testis or other tissues.
Nine of the strongly regulated genes (Rhox5,
Eppin, Galgt1, Drd4 (dopamine receptor D4), TsxPhil. Trans. R. Soc. B (2010)(testis-specific X-linked gene), Gpd1, Tubb3, PCI,
Tpd52l1) were studied in more detail. Decreased
expression in the SCARKO from day 8 up to day 20
(figure 2) and preferential expression in the tubular
compartment could be confirmed by quantitative RT-
PCR (qPCR). Androgen regulation could also be con-
firmed in independent systems such as prepubertal
mice treated with antiandrogens and organotypic cul-
tures of 8-day-old testes (De Gendt et al. 2009).
A functional analysis of the 692 differentially expressed
genes pointed to an over-representation of genes
involved in signal transduction, mitogen-
activated protein kinase (MAPK) activity, cell adhesion,
calcium binding, insulin-like growth factor (IGF) bind-
ing and, perhaps most strikingly, serine protease
inhibition. In fact, five of these SERPINS were downre-
gulated more than twofold in the SCARKO. A
microarray time study (days 8–20) indicated that,
apart from serine protease inhibitors, also serine pro-
teases, cell adhesion molecules, cytoskeletal elements
and extracellular matrix components displayed early
and important differences in expression, supporting
the hypothesis that tubular restructuring and changes
in cell junction dynamics may be processes targeted
by androgens during early puberty. As the AR in
mouse SC appears from day 5 on, a complementary
microarray study was performed on day 6 to search
for genes that might display a very early (maybe transi-
ent) primary response to androgens and that might
subsequently activate secondary cascades of androgen
effects (Willems et al. 2009). Unfortunately, no such
genes could be identified but the study confirmed that
several of the genes identified in the day 10 study
already display responses at or before day 6.
A similar microarray approach was applied to
another SC-selective ARKO model, the Arflox(ex1-neo)/Y;
AMH-Cre mouse and to the floxed hypomorphic
Arflox(ex1-neo)/Y mice used for the generation of this
knockout (see §5b) (Eacker et al. 2007). As discussed,
Arflox(ex1-neo)/Y; AMH-Cre combine a ubiquitous form
of partial androgen insensitivity with an SC-selective
knockout of the AR that looks less complete than in
the SCARKO. In this case, differential gene expression
was studied at an age (8weeks) where there are obviously
differences in testicular cell composition between con-
trols and mutants that may complicate interpretation of
the data. Moreover, the markedly increased levels of
LH observed in these AR mutants may be responsible
for some of the observed effects on gene expression.
The expression of 62 transcripts in the AR mutants
(hypomorphs and selective knockouts) was found to
differ by greater than twofold compared with the wild-
type. Twelve transcripts were found to be uniquely
affected in the SC-selective knockout and 16 additional
transcripts were more affected in the selective knockout
than in the hypomorph. Apart from Rhox5, none
of the genes identified as putatively androgen-
regulated, corresponded to the genes affected more
than twofold in the 10-day-old SCARKO. Functional
analysis suggested an over-representation of genes
involved in metabolic processes and signal transduction.
The cell adhesion molecule claudin 3 was also identified
as a gene with a potentially important role (Meng et al.
2005).
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Figure 2. Expression pattern (from days 8 to 20) for a subset of genes originally identified as differentially expressed in
SCARKO and control mice on day 10. The genes studied are Rhox5 (Pem), Eppin, Galgt1 (b-1,4-acetylgalactosaminyltransfer-
ase), Drd4 (dopamine receptor D4), Tsx (testis-specific X-linked), Gpd1 (glycerol-3-phosphate dehydrogenase 1), Tubb3
(tubulin b3), PCI (protein C inhibitor) and Tpd52l1 (tumour protein D52-like 1). Expression was assessed by microarray
analysis and quantitative RT-PCR (qPCR). Left axis (bars): expression levels measured by qPCR in testes of control and
SCARKO mice of the indicated ages (n ¼ 3). Data were normalized to an external luciferase standard. All values are expressed
as a percentage of the highest value measured for the corresponding gene arbitrarily set at 100. Values represent the mean+
s.e.m. of three measurements. Right axis (lines): gene expression measured by microarray analysis on a pool of mRNA from
three testes of three control or SCARKO mice of the indicated ages. Data were expressed as a percentage of the highest signal
observed for the studied gene, arbitrarily set at 100. Notice that qPCR confirms differential expression between SCARKO and
control on day 10 for all the genes identified by microarray analysis. While the microarray data (reflecting the number of tran-
scripts in a given amount of RNA) suggest a decrease in the transcript levels for most of the studied genes, and for some of
them a loss of differential expression, the qPCR measurements (corrected for exogenously added luciferase and accordingly
reflecting transcript levels per testis) show that this is an artefact caused by the increased contribution of developing germ
cells to the total amount of RNA selectively in the control. The experiment illustrates that genes differentially expressed in
SC may be missed by microarray analysis on samples with different degrees of germ cell maturation. Unfilled bar, control
(qPCR); filled bar, SCARKO (qPCR); unfilled circle, control (microarray); filled circle, SCARKO (microarray).
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script levels in Tfm (ubiquitous knockout) and
control mice on day 20. In total, 4700 differentially
expressed genes were identified (O’Shaughnessy et al.
2007). Further in silico analysis and comparison with
mice lacking germ cells identified 20 genes of a
somatic tubular origin (including Rhox5 and Drd4)
that were significantly downregulated in Tfm testes
and six that were upregulated. Genes downregulated
in the Tfm testis were confirmed to be controlled by
androgens by studies showing upregulation in T-
treated hpg mice. Of the total number of genes
differentially expressed in the Tfm testes, 50 per cent
were associated with vitamin A metabolism, solute
transportation or cytoskeletal function, leading the
authors to suggest that androgens may affect sperm-
atogenesis by modulating the tubular environment
and by control of retinoic acid metabolism.Phil. Trans. R. Soc. B (2010)Two additional studies have used hpgmice or 8-day-
old wild-type mice treated or not with T or DHT to
search explicitly for early effects (4–24 h) of androgens
(Sadate-Ngatchou et al. 2004; Zhou et al. 2005).
These studies will not be discussed given the large
differences in experimental design. For a more detailed
discussion, see a previous overview (Verhoeven et al.
2008). It may be worth mentioning, however, that
Rhox5 was the only gene identified in common with
the above discussed studies on ARKO mice.
It should be obvious from the data summarized
above that there is very limited overlap between the
sets of androgen-regulated genes identified in the
available studies. This lack of consensus is undoubt-
edly largely owing to differences in experimental
set-up.
Studies differ widely with respect to the age of the
animals investigated, time and duration of androgen
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AR in SC (as compared with the AR in other testicular
cells), sensitivity to confounding factors such as sec-
ondary changes in gonadotropin secretion affecting
testicular gene expression. Treatment/knockout-
related differences in testicular cell composition also
represent an underestimated confounding factor
(figure 2). Accordingly, the data available should be
interpreted with caution and should probably be
regarded as complementary rather than contradictory.
(d) Pathways involved in androgen-mediated
control: topics for hypothesis-driven research
Despite the heterogeneity of the data available and the
lack of consensus, some tentative conclusions seem
appropriate:
— All the microarray studies, even those focusing on
very early effects, identify relatively large sets of
transcripts that are subject to androgen regulation.
This suggests that androgens may affect the
expression of a broad spectrum of genes rather
than a few key genes. Further studies are obviously
needed to confirm that all these putative target
genes are indeed regulated by androgens, to find
out which of them are expressed in SC, and to dis-
tinguish primary and secondary actions of
androgens. In addition, however, and as illustrated
in figure 2, it should be noted that microarrays
comparing gene expression in testes with
mutation/treatment-induced differences in cell
composition may fail to identify several androgen-
regulated genes expressed in SC.
— Rhox5 remains the lead gene in the search for SC-
specific genes directly affected by androgen action.
It is the only gene invariably identified in all the
summarized studies. Moreover, it is one of the
very few androgen-regulated transcription factors
identified. The finding that this gene is a
member of a large homeobox family of genes, sev-
eral of which also expressed in SC, may explain
why, despite its suggested essential role, a knock-
out has only limited effects on fertility. Further
investigations addressing androgen regulation and
function of Rhox5 orthologues in other species
including the human are badly needed.
— Some functional families of transcripts seem to be
prominently present in the lists of candidate
androgen-regulated genes (figure 3). Proteases
and protease inhibitors, cell adhesion molecules
and cytoskeletal elements have been found to be
over-represented in the microarray data (Denolet
et al. 2006a; Eacker et al. 2007; O’Shaughnessy
et al. 2007), suggesting that tubular restructuring
(related to pubertal development and/or germ
cell migration) and concomitant changes in cell
junction dynamics may be important targets for
androgen action. These changes together with
modifications in cell metabolism and in the
expression of several carriers involved in solute
transportation (Eacker et al. 2007; O’Shaughnessy
et al. 2007) point to a probable role of androgens
in the creation of the specific and unique environ-
ment needed for germ cell development.Phil. Trans. R. Soc. B (2010)Parenthetically, a more directed search for genes
known to be important in SC function also
revealed marked changes in the expression of tran-
scripts encoding junction proteins (claudin 11,
occludin, gelsolin) and cytoskeletal elements
(vimentin) (Wang et al. 2006). Moreover, one of
the most characteristic features of the tubular
restructuring process, the formation of the SC
barrier, has been shown to be disturbed in Tfm
mice (Fritz et al. 1983) as well as in Arflox(ex1-neo)/Y;
AMH-Cremice (Meng et al. 2005).This disturbance
has been related to a decreased expression of the
tight junction protein claudin 3 in the SC of the
Arflox(ex1-neo)/Y; AMH-Cre mice. Recent data indi-
cate, however, that changes in two other tight-
junction-related proteins, claudin 11 and Jam3,
precede those observed in claudin 3 (Willems et al.
2009). Moreover, apart from their effects on gene
expression, androgens may also affect junction
dynamics by accelerating both endocytosis and
recycling of junction proteins (including occludin,
Jam-A and N-cadherin) via a clathrin-mediated
pathway (Yan et al. 2008).
— An intriguing observation is that two studies iden-
tified several genes involved in vitamin A
metabolism, suggesting a possible link between
androgen action and retinoic acid metabolism
and/or action (Eacker et al. 2007; O’Shaughnessy
et al. 2007). Given the increasing amount of evi-
dence that retinoic acid may play a role in the
control of meiosis, the possibility of such a link
certainly merits further investigation (Wolgemuth
2006). Interestingly, these genes were not ident-
ified in the SCARKO model and the mentioned
studies were both based on animals with a ubiqui-
tous (complete or incomplete) form of androgen
insensitivity, suggesting that SC may not be the
main or only target cells involved in these specific
effects of androgens.
8. GENERAL CONCLUSIONS
The development of transgenic mouse models display-
ing various defects in androgen signalling and the
application of powerful transcription profiling tech-
niques have contributed substantially to our
understanding of the cellular and molecular mechan-
isms by which androgens control spermatogenesis.
A comparison of germ cell development in cell-
selective knockouts of the AR in somatic cells (SC,
peritubular myoid cells, Leydig cells) as well as germ
cells of the testis unambiguously points to the SC as
the main mediator of androgen action in the control
of spermatogenesis. However, it is obvious that SC
are very peculiar androgen target cells. The cyclic
changes in SC-AR expression during the spermato-
genic cycle and the finding that isolated SC display a
loss in the expression of prototypic androgen target
genes such as Rhox5 and a loss of androgen responsive-
ness underline that the androgen responsiveness of SC
depends critically on a specific microenvironment
including the interactions of SC with germ cells. The
mechanisms by which this environment controls the
response of SC to androgens certainly merit further
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Figure 3. Molecular mediators of androgen action on spermatogenesis. (b) Indicates the main steps in spermatogenesis
affected by androgens. In (a), a number of processes and molecular targets are summarized that are identified as potential
targets of SC-mediated androgen action by the microarray experiments discussed in the text. The numbers in the centrally
represented SC (yellow) refer to the processes summarized on (a). Developing germ cells are indicated in blue. Microtubules
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ectoplasmic specializations are represented by actin bundles (red) and a cistern of endoplasmic reticulum.
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cells may contribute to some specific effects such as
the perinatal proliferation of SC and may modulate
the expression of some SC genes, but these effects
are apparently not crucial for male fertility.
The finding that selective and total ablation of the
AR in SC causes a complete block in meiosis confirms
the key role of androgens in the completion of
meiotic progression and lends further support to the
contention that meiosis may require lower concen-
trations of androgens than subsequent steps in germ
cell development. Accordingly, the identification of
androgen-regulated genes that play a decisive role in
the control of meiosis is a central issue in our under-
standing of androgen action in spermatogenesis.
Mice with a selective ablation of the AR in SC such
as the SCARKO represent one of the most powerful
tools to search for such genes. Whether the genes
and pathways involved in androgen-mediated control
of meiosis are the same as those involved in subsequent
steps of spermatogenesis remains to be investigated.
The complete block in meiosis developed by
SCARKO animals implies that they may not be suit-
able to identify all the genes involved in post-meiotic
effects of androgens. Generation of inducible knock-
out models that allow cell-specific as well as temporal
control of AR inactivation may create novel experi-
mental paradigms to overcome this possible
limitation.Phil. Trans. R. Soc. B (2010)Selective defects in androgen action in SC have not
been described in the human, but two recently devel-
oped mouse models, the hypomorphic mouse with
diminished androgen expression (Arflox(ex1-neo)/Y) and
the mouse with an increased length of the CAG
repeat of the AR, mimick human diseases in which
spermatogenesis is specifically affected without
obvious disturbances in male sexual development. A
third model, the SPARKI mouse, suggests that it
may be possible to interfere selectively with the effects
of androgens on reproductive functions without
impeding their anabolic actions on growth and skeletal
development (table 1).
It is obvious that the search for molecular mediators
bridging the gap between activation of the AR in SC
and control of germ cell development has not yet
resulted in definitive and unambiguous answers. The
expectation or hope to identify one or a few key
mediators of androgen action has not been fulfilled.
In fact, transcriptional profiling studies in mice
models with different defects in androgen signalling
or in mice treated or not with androgens have invari-
ably resulted in relatively large sets of genes that are
putatively regulated by androgens. Whether key
genes showing an early and direct response to andro-
gens and initiating subsequent cascades of androgen
effects exist is a question that still merits further inves-
tigation. The presently identified sets of androgen-
regulated genes show surprisingly little overlap. As
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in experimental set-up or in the selected experimental
paradigms. Moreover, despite the fact that many genes
seem to respond to androgen action, the number of
genes displaying a twofold or higher change in
expression is limited, and for many genes confirmation
of androgen regulation by independent techniques and
in other experimental systems seems warranted. Fur-
thermore, it is often unclear whether the genes
identified are preferentially or exclusively expressed
in SC and whether androgen regulation is direct or
indirect. Despite all these limitations, a comparison
of the lists of genes identified as being androgen-regu-
lated with data from physiological studies on the steps
of spermatogenesis that are most sensitive to androgen
action suggests that a number of relevant functions
and processes are prominently present (figure 3).
Examples include genes involved in tubular restructur-
ing, cell adhesion and junction dynamics, cytoskeletal
organization, metabolism, solute transportation and
vitamin A metabolism. The role of androgens in
these processes is at present the subject of intensive
research in several laboratories. It may reasonably be
expected that these studies will soon result in reliable
lists of genes reflecting androgen action in SC and in
a better understanding of the molecular mechanisms
by which androgens control spermatogenesis. A cru-
cial question remains whether these genes, identified
based upon mouse models, will also prove to be rele-
vant mediators of androgen action in the testes of
other species including men. Biochemical parameters
of androgen action in human SC would be extremely
valuable diagnostic tools to explore defects in andro-
gen action in patients with idiopathic infertility.
Moreover, some of these androgen-regulated genes
might represent interesting targets to modulate the
effects of androgens selectively in the testis and/or to
develop novel male contraceptives.NOTE ADDED IN PROOF
While this review was in proof a paper appeared show-
ing that—in contrast with previous observations
(Zhang et al. 2006)—more appropriate inactivation
of the AR in peritubular myoid cells causes major dis-
turbances in spermatogenesis, comparable to those
observed in SC-selective knockouts (Welsh et al.
2009). Also in this model, however, the effects on
spermatogenesis may largely be mediated by second-
ary changes in SC function.
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